Rare diseases
Investigational molecules
Locations
Back to Germany1 770 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
GermanyFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
GermanyTulisokibart for Psoriatic Arthritis in Adults
GermanyA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
GermanyComparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer
GermanyA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
GermanyA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
GermanyA study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy
GermanyA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
GermanyA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
GermanyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
GermanyA study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
